Repurposed GI Drugs in the Treatment of COVID-19.
作者信息
Aguila Enrik John T, Cua Ian Homer Y
机构信息
Institute of Digestive and Liver Diseases, St. Luke's Medical Center Global City, Rizal Drive cor. 32nd St. and 5th Ave., Taguig City, 1634, Metro Manila, Philippines.
出版信息
Dig Dis Sci. 2020 Aug;65(8):2452-2453. doi: 10.1007/s10620-020-06430-z. Epub 2020 Jun 29.
Abstract
摘要
相似文献
1
Repurposed GI Drugs in the Treatment of COVID-19.用于治疗新冠肺炎的重新利用的胃肠道药物。
Dig Dis Sci. 2020 Aug;65(8):2452-2453. doi: 10.1007/s10620-020-06430-z. Epub 2020 Jun 29.
2
Interim Management of COVID-19 by Repurposed Homeopathic Medicines.用顺势疗法药物对新冠病毒病进行临时管理
Homeopathy. 2020 Aug;109(3):182-183. doi: 10.1055/s-0040-1713004. Epub 2020 Jun 9.
3
Treatments for COVID-19: emerging drugs against the coronavirus.新冠病毒病的治疗方法：对抗冠状病毒的新型药物
Acta Biomed. 2020 Jun 30;91(3):ahead of print. doi: 10.23750/abm.v91i3.9982.
4
Reply to Fenton : An Expanded COVID-19 Telemedicine Intermediate Care Model Using Repurposed Hotel Rooms.对芬顿的回复：一种利用改造后的酒店房间的扩展型新冠病毒远程医疗中级护理模式。
Am J Respir Crit Care Med. 2020 Oct 15;202(8):1192-1193. doi: 10.1164/rccm.202008-3063LE.
5
Treatments for COVID-19: emerging drugs against the coronavirus - reply.新型冠状病毒肺炎的治疗方法：对抗冠状病毒的新型药物——回复
Acta Biomed. 2020 Jun 30;91(3):ahead of print. doi: 10.23750/abm.v91i3.10108.
6
An Expanded COVID-19 Telemedicine Intermediate Care Model Using Repurposed Hotel Rooms.一种利用改造后的酒店房间的扩展型新冠病毒肺炎远程医疗中级护理模式
Am J Respir Crit Care Med. 2020 Oct 15;202(8):1190-1192. doi: 10.1164/rccm.202007-2902LE.
7
News Feature: To counter the pandemic, clinicians bank on repurposed drugs.新闻特写：为抗击疫情，临床医生寄希望于 repurposed drugs。
注：“repurposed drugs”直译为“重新利用的药物”，在医学领域可能有特定含义，比如“旧药新用”等，需结合上下文准确理解其确切意思。
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10616-10620. doi: 10.1073/pnas.2007346117. Epub 2020 Apr 29.
8
Cardiac drugs and outcome in COVID-19.新冠疫情中的心脏药物与治疗结果
QJM. 2020 Jul 1;113(7):523-524. doi: 10.1093/qjmed/hcaa127.
9
Evaluation of SARS-CoV-2 in the female reproductive tract of COVID-19 patients: A prospective study.新冠病毒肺炎患者女性生殖道中严重急性呼吸综合征冠状病毒2的评估：一项前瞻性研究。
J Biol Regul Homeost Agents. 2020;34(5):1885-1888. doi: 10.23812/20-352-L.
10
The Impact of COVID-19 on Italy: A Lesson for the Future.新冠疫情对意大利的影响：未来之鉴。
Int J Occup Environ Med. 2020 Jul 10;11(3):151-152. doi: 10.34172/ijoem.2020.1984. Epub 2020 Mar 30.
引用本文的文献
1
Redirecting pantoprazole as a metallo-beta-lactamase inhibitor in carbapenem-resistant .将泮托拉唑重新用作耐碳青霉烯类细菌中的金属β-内酰胺酶抑制剂。
Front Pharmacol. 2024 Mar 12;15:1366459. doi: 10.3389/fphar.2024.1366459. eCollection 2024.
2
Role of Cytochrome P450 2C9 in COVID-19 Treatment: Current Status and Future Directions.细胞色素 P450 2C9 在 COVID-19 治疗中的作用：现状与未来方向。
Eur J Drug Metab Pharmacokinet. 2023 May;48(3):221-240. doi: 10.1007/s13318-023-00826-8. Epub 2023 Apr 24.
3
Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm.法莫替丁通过激活迷走神经炎症反射减轻细胞因子风暴。
Mol Med. 2022 May 16;28(1):57. doi: 10.1186/s10020-022-00483-8.
4
Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm.法莫替丁激活迷走神经炎症反射以减轻细胞因子风暴。
Res Sq. 2022 Apr 11:rs.3.rs-1493296. doi: 10.21203/rs.3.rs-1493296/v1.
5
Potential Effects of Ibuprofen, Remdesivir and Omeprazole on Dexamethasone Metabolism in Control Sprague Dawley Male Rat Liver Microsomes (Drugs Often Used Together Alongside COVID-19 Treatment).布洛芬、瑞德西韦和奥美拉唑对合用治疗 COVID-19 时常用药物地塞米松在 Sprague Dawley 雄性大鼠肝微粒体中代谢的潜在影响。
Molecules. 2022 Mar 30;27(7):2238. doi: 10.3390/molecules27072238.
6
Anti-infective properties of proton pump inhibitors: perspectives.质子泵抑制剂的抗感染特性：观点。
Int Microbiol. 2022 Jan;25(1):217-222. doi: 10.1007/s10123-021-00203-y. Epub 2021 Sep 3.
7
A Birds-Eye (Re)View of Acid-Suppression Drugs, COVID-19, and the Highly Variable Literature.酸抑制药物、COVID-19及高度多样化文献的鸟瞰（再审视）
Front Pharmacol. 2021 Aug 11;12:700703. doi: 10.3389/fphar.2021.700703. eCollection 2021.
8
Near-physiological-temperature serial crystallography reveals conformations of SARS-CoV-2 main protease active site for improved drug repurposing.近生理温度下的连续结晶学揭示了 SARS-CoV-2 主蛋白酶活性位点的构象，有助于改进药物再利用。
Structure. 2021 Dec 2;29(12):1382-1396.e6. doi: 10.1016/j.str.2021.07.007. Epub 2021 Aug 16.
9
Paradoxical relationship between proton pump inhibitors and COVID-19: A systematic review and meta-analysis.质子泵抑制剂与2019冠状病毒病之间的矛盾关系：一项系统评价与荟萃分析
World J Clin Cases. 2021 Apr 26;9(12):2763-2777. doi: 10.12998/wjcc.v9.i12.2763.
10
The Immunopathology of COVID-19 and the Cannabis Paradigm.新型冠状病毒肺炎的免疫病理学与大麻范例。
Front Immunol. 2021 Feb 12;12:631233. doi: 10.3389/fimmu.2021.631233. eCollection 2021.
本文引用的文献
1
Putative Mechanisms of Diarrhea in COVID-19.新型冠状病毒肺炎腹泻的潜在机制
Clin Gastroenterol Hepatol. 2020 Dec;18(13):3054-3055. doi: 10.1016/j.cgh.2020.06.008. Epub 2020 Jun 12.
2
Clinical Insights into the Gastrointestinal Manifestations of COVID-19.COVID-19 相关胃肠道表现的临床观察
Dig Dis Sci. 2020 Jul;65(7):1932-1939. doi: 10.1007/s10620-020-06362-8. Epub 2020 May 23.
3
Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study.法莫替丁的使用与住院COVID-19患者临床结局改善相关：一项倾向评分匹配的回顾性队列研究。
Gastroenterology. 2020 Sep;159(3):1129-1131.e3. doi: 10.1053/j.gastro.2020.05.053. Epub 2020 May 22.
4
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.通过计算方法分析严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的治疗靶点并发现潜在药物
Acta Pharm Sin B. 2020 May;10(5):766-788. doi: 10.1016/j.apsb.2020.02.008. Epub 2020 Feb 27.
5
TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections.TMPRSS2：抗流感病毒和冠状病毒感染治疗的潜在靶标。
Biochimie. 2017 Nov;142:1-10. doi: 10.1016/j.biochi.2017.07.016. Epub 2017 Aug 1.
6
The proton pump inhibitor lansoprazole inhibits rhinovirus infection in cultured human tracheal epithelial cells.质子泵抑制剂兰索拉唑可抑制培养的人气管上皮细胞中的鼻病毒感染。
Eur J Pharmacol. 2005 Feb 21;509(2-3):201-10. doi: 10.1016/j.ejphar.2004.12.042.
7
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.SARS冠状病毒功能性受体ACE2蛋白的组织分布。理解SARS发病机制的第一步。
J Pathol. 2004 Jun;203(2):631-7. doi: 10.1002/path.1570.
8
The effect of histamine type 2 receptor antagonists on human immunodeficiency virus (HIV) replication: identification of a new class of antiviral agents.组胺2型受体拮抗剂对人类免疫缺陷病毒（HIV）复制的影响：一类新型抗病毒药物的鉴定。
Life Sci. 1996;59(23):PL 365-70. doi: 10.1016/s0024-3205(96)00553-x.
Zotero 插件